IL15 and renal cell carcinoma: In the first in-human study, metastatic patients with melanoma and renal cell carcinoma (RCC) treated with intravenous (i.v.)recombinant human IL-15 (rh-IL15) displayed an expansion of NK cells, plus memory and γδ T cells [29].